Bridget C.E. Dooling, B.B.A., J.D.
Education
-
George Mason University School of Law (J.D. 2006)
-
The George Washington University (B.B.A. 2001)
Biography
Bridget Dooling is a nationally recognized expert on administrative law and regulatory policy. Her scholarship on regulatory matters has been published in leading legal journals including the Duke Law Journal, the Administrative Law Review, the Minnesota Law Review Headnotes, the American University Law Review and The Annals of Health Law.
Professor Dooling teaches courses on legislation and regulation, administrative law and other regulatory topics. She recently completed a 3-year term on the Council of the American Bar Association’s Section of Administrative Law and Regulatory Practice and is a Senior Fellow at the Administrative Conference of the United States (ACUS).
Prior to joining the faculty at Ohio State, Dooling was a research professor with the George Washington University Regulatory Studies Center and a professor of law (by courtesy) at GW Law. Before that, Professor Dooling spent over 10 years in the federal government as a deputy chief, senior policy analyst and attorney for the Office of Information and Regulatory Affairs at the U.S. Office of Management and Budget. She also served on Biden-Harris Presidential Transition Team as a member of the agency review teams for the Office of Management and Budget and the National Archives and Records Administration.
Dooling is active with the Food & Drug Law Institute, currently serving on the editorial board of the Food & Drug Law Journal. She is a regular contributor to the Yale Journal on Regulation’s Notice & Comment blog and the Brookings Institute’s Series on Regulatory Process and Perspective.
Ghostwriting the Government, 109 Marq. L. Rev. (forthcoming 2026)
Corner Post, Caremark, and the Rule of Law: When Corporate Fiduciaries Should Reject Corner Post's Invitation to Sue, 94 U. Cin. L. Rev. (forthcoming 2026)
Delay, Politics, and Expertise in OIRA Tax Review, 45 Va. Tax Rev. (2025)
Applying the Regulatory Report Card to Tax Rules, 13 J. Benefit-Cost Analysis (2025)
Links: SSRN
Regulatory Body Shops, 73 Duke L.J. 1677 (2024)
Links: SSRN
Adoption of Methadone Take Home Policy by U.S. State Opioid Treatment Authorities During COVID-19, 124 Int'l J. Drug Pol'y 104302 (2024)
Competing Narratives in OIRA Review of Tax Regulations, 19 J.L. Econ. & Pol'y 272 (2024)
Links: SSRN
Methadone's Regulatory Thicket, 32 Annals Health L. 191 (2023)
Links: SSRN
Beyond Republicans and the Disapproval of Regulations: A New Empirical Approach to the Congressional Review Act, 20 Empirical Legal Stud. 472 (2023)
Links: SSRN
Pandemic Telehealth Flexibilities for Buprenorphine Treatment: A Synthesis of Evidence and Policy Implications for Expanding Opioid Use Disorder Care in the United States, 1 Health Affairs Scholar QXAD013 (2023)